Evidence map›Paper›PMID 26792838›Full record

ArticleMolecular biology of the cell2016

Nanoscopic cell-wall architecture of an immunogenic ligand in Candida albicans during antifungal drug treatment.

Jia Lin, Michael J Wester, Matthew S Graus, Keith A Lidke, Aaron K Neumann

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. γ9δ2T cell diversity and the receptor interface with tumor cells.The Journal of clinical investigation · 2020
    Article
  13. Caspofungin Induced Cell Wall Changes ofFrontiers in cellular and infection microbiology · 2020
    Article
  14. Article
  15. β-1,3-glucan-lackingVirulence · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Titan cell production inCell surface (Amsterdam, Netherlands) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jia LinCenter for Spatiotemporal Modeling of Cell Signaling, University of New Mexico, Albuquerque, NM 87131 Department of Pathology, University of New Mexico, Albuquerque, NM 87131.
Michael J WesterCenter for Spatiotemporal Modeling of Cell Signaling, University of New Mexico, Albuquerque, NM 87131 Department of Mathematics and Statistics, University of New Mexico, Albuquerque, NM 87131.
Matthew S GrausCenter for Spatiotemporal Modeling of Cell Signaling, University of New Mexico, Albuquerque, NM 87131 Department of Pathology, University of New Mexico, Albuquerque, NM 87131.
Keith A LidkeCenter for Spatiotemporal Modeling of Cell Signaling, University of New Mexico, Albuquerque, NM 87131 Department of Physics and Astronomy, University of New Mexico, Albuquerque, NM 87131.
Aaron K NeumannCenter for Spatiotemporal Modeling of Cell Signaling, University of New Mexico, Albuquerque, NM 87131 Department of Pathology, University of New Mexico, Albuquerque, NM 87131 akneumann@salud.unm.edu.
University of New Mexico · US

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
UNM TRAININGP50GM085273 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI EDWARDS, JEREMY S · 2009 to 2018
$26.1M
Biology of Infectious Diseases &InflammationT32AI007538 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Michelle A Ozbun · 1998 to 2026
$5.2M
Nano and Microscale Molecular Machines for Innate Immune Sensing of CandidaR01AI116894 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI NEUMANN, AARON KURT · 2015 to 2019
$1.9M
Integrative Cancer Nanoscience and Microsystems (IC-NSMS) Training CenterR25CA153825 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI DATYE, ABHAYA KRISHNA, OLIVER, JANET M. · 2010 to 2014
$1.8M
NCI NIH HHS P30 CA118100NCI NIH HHS P30CA118100NCI NIH HHS R25 CA153825NIAID NIH HHS R01 AI116894NIAID NIH HHS R01AI116894NIAID NIH HHS T32 AI007538NIGMS NIH HHS 5P50GM085273NIGMS NIH HHS P50 GM085273
6 · The paper itself

Abstract

The cell wall of Candida albicans is composed largely of polysaccharides. Here we focus on β-glucan, an immunogenic cell-wall polysaccharide whose surface exposure is often restricted, or "masked," from immune recognition by Dectin-1 on dendritic cells (DCs) and other innate immune cells. Previous research suggested that the physical presentation geometry of β-glucan might determine whether it can be recognized by Dectin-1. We used direct stochastic optical reconstruction microscopy to explore the fine structure of β-glucan exposed on C. albicans cell walls before and after treatment with the antimycotic drug caspofungin, which alters glucan exposure. Most surface-accessible glucan on C. albicans yeast and hyphae is limited to isolated Dectin-1-binding sites. Caspofungin-induced unmasking caused approximately fourfold to sevenfold increase in total glucan exposure, accompanied by increased phagocytosis efficiency of DCs for unmasked yeasts. Nanoscopic imaging of caspofungin-unmasked C. albicans cell walls revealed that the increase in glucan exposure is due to increased density of glucan exposures and increased multiglucan exposure sizes. These findings reveal that glucan exhibits significant nanostructure, which is a previously unknown physical component of the host-Candida interaction that might change during antifungal chemotherapy and affect innate immune activation.

Indexed as

Antifungal Agentsbeta-GlucansCandida albicansCarbohydrate ConformationCaspofunginCell WallDectin-1Dendritic CellsEchinocandinsHumansLectins, C-TypeLigandsLipopeptidesAntifungal Agentsbeta-GlucansCaspofunginDectin-1EchinocandinsLectins, C-TypeLigandsLipopeptides

Identifiers

PMID26792838
PMCPMC4791122
OpenAlexW2256093600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.